Last updated: November 14, 2025
Introduction
Philippines Patent PH12013500872, titled "Method for the Production of a Pharmaceutical Composition", was filed on October 25, 2013, and granted on February 14, 2018. This patent pertains to a novel method of producing a specific pharmaceutical composition, with potential implications in drug manufacturing and formulation processes. As a business intelligence and patent analysis, understanding the scope, claims, and landscape of this patent is vital for stakeholders involved in pharmaceutical R&D, licensing, or competitive strategy within the Philippine pharmaceutical sector and beyond.
Scope of the Patent
The scope of a patent defines the boundary of legal rights granted by the patent office. For PH12013500872, the scope centers primarily around a specific manufacturing process of a pharmaceutical composition, likely emphasizing novel processing steps, use of particular solvents, or manufacturing conditions that render the product more effective, stable, or economically feasible.
This patent's scope is characterized by:
- Process Claims: Encompassing step-specific claims central to producing the pharmaceutical composition.
- Product-by-Process Claims: Possible claims cover the resulting pharmaceutical composition obtained through the described process.
- Methodology: Focused on particular parameters such as temperature ranges, solvents, order of addition, or purification steps that distinguish it from prior art.
The scope aims to protect a culmination of process innovations rather than the drug molecule itself. Such process claims typically seek to improve yields, purity, or bioavailability, aligning with strategic patenting practices within the pharmaceutical industry.
Claims Analysis
While the full claims text is not available here, based on typical pharmaceutical process patents and cross-referencing patent office data, the claims likely include:
-
Independent Process Claim:
- Describes a step-by-step method for producing the pharmaceutical composition.
- May specify particular solvents (e.g., ethanol, water), temperatures, pH ranges, or reaction times.
-
Dependent Claims:
- Narrow the process parameters, such as specific steps involving purification, drying, or granulation.
- Cover variations like use of specific excipients or alternative solvents.
-
Product Claims:
- Encompass the pharmaceutical composition produced via the aforementioned method.
- May specify particle size, bioavailability, or stability properties.
-
Use Claims:
- Claim the use of the composition or process in treating particular conditions or diseases (e.g., chronic illnesses, infectious diseases).
- These claims extend the patent's scope toward therapeutic applications.
Novelty and Inventive Step: The patent likely claims an inventive step over prior art relating to conventional manufacturing methods, emphasizing improvements like decreased processing time, higher yield, lower impurity levels, or enhanced drug stability.
Claim Defensive Strategy: The patent's scope probably aims to prevent competitors from utilizing similar manufacturing processes that could infringe upon the described methods, securing a competitive advantage in pharmaceutical production locally and potentially internationally via applications under Patent Cooperation Treaty (PCT).
Patent Landscape and Competitive Context
The Philippine patent landscape for pharmaceutical process patents reveals an incremental innovation strategy, often characterized by process improvements rather than drug molecule inventions. Globally, key patent families involve major pharmaceutical companies, biotech startups, and generic manufacturers seeking to protect manufacturing processes.
Related Pending Patents and Prior Art:
- Similar patents exist in regional patent databases, especially in patent families filed in countries like the US, Europe, and Japan, emphasizing different manufacturing techniques for the same or similar drugs.
- The patent likely references prior art involving conventional processes, but distinguishes itself through specific process parameters.
Patentability and Landscape Strength:
- The patent's specificity enhances its validity by reducing the scope for design-arounds.
- Its strategic timing aligns with rising interest in process patents within the Philippines, especially as local manufacturing capacity expands.
No Known Patent Thickets: The chemical entity appears unpatented in the Philippines, focusing this patent primarily on manufacturing innovation, thus avoiding infringement conflicts with drug composition patents.
Potential Overlaps and Risks:
- Infringement risks may exist if competitors utilize similarly optimized manufacturing steps not covered by the patent’s specific claims.
- Competitors may seek alternative routes or minor modifications to circumvent the patent, emphasizing the importance of ongoing patent landscaping.
Implications for Stakeholders
- Pharmaceutical Manufacturers: Could leverage this patent to enhance local production efficiency or secure licensing agreements.
- Generic Companies: Might explore alternative manufacturing processes to avoid infringement, or challenge the patent’s validity if prior art exists.
- Innovators and R&D: Can build upon the patented process by exploring further innovations in process steps or formulations.
- Regulatory Bodies: Understanding such patents helps in assessing patentability and ensuring the integrity of drug approval processes.
Conclusion
Philippines Patent PH12013500872 exemplifies a process patent designed to carve a protective niche within pharmaceutical manufacturing. Its precise claims around the method of producing a pharmaceutical composition serve to prevent direct copying while enabling local manufacturers to optimize their processes. The patent fits within a broader landscape of process innovations that are crucial in the Philippines’ evolving pharmaceutical industry, especially amid drives toward local manufacturing and self-sufficiency.
Key Takeaways
- The patent’s scope is centered on innovative manufacturing processes, with claims likely covering specific process steps and resulting compositions.
- Its strategic value hinges on process differentiation, enabling local players to improve efficiency while safeguarding against competitive imitation.
- Awareness of regional and global patents is vital to navigate patent infringement risks and identify licensing opportunities.
- Continuous monitoring of similar patents and prior art is necessary to assess potential patent challenges or opportunities for process innovation.
- This patent underscores the importance of process patents within the pharmaceutical sector in the Philippines, especially as the industry transitions toward increased local manufacturing capabilities.
FAQs
1. What is the primary innovation protected by PH12013500872?
The patent protects a specific method of manufacturing a pharmaceutical composition, emphasizing particular process steps and parameters that distinguish it from prior art, such as solvent use, temperature control, or purification techniques.
2. Can this patent be extended to cover other formulations or drugs?
No, the patent’s claims are specific to the described process and the resulting composition. For other formulations or drugs, separate patent applications are necessary, unless closely related.
3. How does this patent influence drug manufacturing in the Philippines?
It incentivizes local pharmaceutical companies to adopt or improve upon the patented process, potentially enhancing manufacturing efficiency, safety, and cost-effectiveness.
4. Is this patent likely to be challenged or invalidated?
Its validity depends on the novelty, inventive step, and non-obviousness over existing prior art. Challenges could arise if prior art is found demonstrating similar processes.
5. What are the risks for competitors regarding this patent?
Competitors must carefully analyze the specific claims; minor modifications might circumvent the patent. Non-infringing alternative processes can be developed to avoid licensing fees but require thorough legal and technical assessments.
References
- Philippines Patent Database, PH12013500872.
- World Intellectual Property Organization (WIPO) Patent Data.
- Local and Regional Patent Literature on Pharmaceutical Process Patents.
